Marcee Wharton
Physician Assistant · Mesa, AZNPI 1760442784
Payments from drug & device makers
Across 141 payments — averaging $16.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma US Inc$314
- Novo Nordisk$271
- Boehringer Ingelheim$255
- AbbVie$181
- Amarin Pharma, Inc.$120
- Sunovion Pharmaceuticals Inc.$115
- plus $1K from 25 others
What the payments were for
- Food & beverage$2,19796%
- Education$804%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astellas Pharma US Inc | 13 | $314 |
| Novo Nordisk | 25 | $271 |
| Boehringer Ingelheim | 13 | $255 |
| AbbVie | 12 | $181 |
| Amarin Pharma, Inc. | 9 | $120 |
| Sunovion Pharmaceuticals Inc. | 5 | $115 |
| Lilly USA, LLC | 7 | $100 |
| Nestle Healthcare Nutrition Inc. | 3 | $79 |
| Pfizer | 5 | $68 |
| Abbott | 4 | $66 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $65 |
| AstraZeneca | 5 | $64 |
| GSK | 4 | $63 |
| Amgen | 4 | $58 |
| Bayer | 3 | $47 |
| Biohaven Pharmaceuticals, Inc. | 3 | $47 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $46 |
| Corcept Therapeutics | 1 | $38 |
| Merck | 3 | $38 |
| Medicure Pharma Inc. | 1 | $37 |
| Currax Pharmaceuticals LLC | 2 | $27 |
| Arbor Pharmaceuticals, Inc. | 2 | $25 |
| Eisai Inc. | 1 | $25 |
| Hologic Sales And Service, LLC | 1 | $23 |
| Insulet Corporation | 1 | $19 |
| Xeris Pharmaceuticals, Inc. | 1 | $18 |
| Dexcom, Inc. | 1 | $17 |
| Novartis | 1 | $17 |
| Nevro Corp. | 1 | $14 |
| Collegium Pharmaceutical, Inc. | 1 | $14 |
| Corium, LLC | 1 | $7 |
How this compares
$2,277 in reported general payments places this provider in the 80th percentile of 2,888 physician assistant providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 76 | $85,682 |
| JardianceEmpagliflozin | 67 | $70,169 |
| AtivanLorazepam | 12 | $43,169 |
| MyrbetriqMirabegron | 44 | $39,994 |
| FarxigaDapagliflozin Propanediol | 36 | $37,974 |
| MounjaroTirzepatide | 27 | $35,665 |
| TrulicityDulaglutide | 22 | $33,608 |
| JanuviaSitagliptin Phosphate | 21 | $17,179 |
| RybelsusSemaglutide | 20 | $16,554 |
| EliquisApixaban | 13 | $16,397 |
| Tresiba Flextouch U-100Insulin Degludec | 20 | $13,005 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 11 | $9,957 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 35 | $7,097 |
| Atorvastatin Calcium | 583 | $4,366 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 14 | $3,831 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $271 | $102,23696 claims |
| Boehringer IngelheimJardiance | $255 | $70,16967 claims |
| Lilly USA, LLCMounjaro, Trulicity | $100 | $69,27349 claims |
| Astellas Pharma US IncMyrbetriq | $314 | $39,99444 claims |
| AstraZenecaFarxiga | $64 | $37,97436 claims |
| MerckJanuvia | $38 | $17,17921 claims |
| PfizerEliquis | $68 | $16,39713 claims |
| GSKTrelegy Ellipta | $63 | $9,95711 claims |
| AbbVieSynthroid | $181 | $2,28426 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 2,888 physician assistant providers in Arizona.
Other physician assistant in Mesa
- Jessica RosenblumMesa$19K
- Katrina McDanielMesa$14K
- Jenna HiltonGilbert$637K
- Kara GoodingScottsdale$625K
- Ginna GranrothScottsdale$211K
- Nicole MaderaGlendale$128K
- Candace RyanGlendale$113K
- Alyssa BoschenPhoenix$86K
- Christopher BeroScottsdale$81K
- Katherine MinorPhoenix$76K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.